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Abstract
Purpose The goal of the Pregnancy, Race, Environment,
Genes study was to understand how social and
environmental determinants of health (SEDH), pregnancyspecific environments (PSE) and biological processes
influence the timing of birth and account for the racial
disparity in preterm birth. The study followed a racially
diverse longitudinal cohort throughout pregnancy and
included repeated measures of PSE and DNA methylation
(DNAm) over the course of gestation and up to 1 year into
the postpartum period.
Participants All women were between 18 and 40 years
of age with singleton pregnancies and no diagnosis of
diabetes or indication of assisted reproductive technology.
Both mother and father had to self-identify as either
African-American (AA) or European-American (EA).
Maternal peripheral blood samples along with self-report
questionnaires measuring SEDH and PSE factors were
collected at four pregnancy visits, and umbilical cord blood
was obtained at birth. A subset of participants returned for
two additional postpartum visits, during which additional
questionnaires and maternal blood samples were collected.
The pregnancy and postpartum extension included n=240
(AA=126; EA=114) and n=104 (AA=50; EA=54), respectively.
Findings to date One hundred seventy-seven women
(AA=89, EA=88) met full inclusion criteria out of a total of
240 who were initially enrolled. Of the 63 participants who
met exclusion criteria after enrolment, 44 (69.8%) were
associated with a medical reason. Mean gestational age at
birth was significantly shorter for the AA participants by 5.1
days (M=272.5 (SD=10.5) days vs M=277.6 (SD=8.3)).
Future plans Future studies will focus on identifying key
environmental factors that influence DNAm change across
pregnancy and account for racial differences in preterm birth.

Introduction
Background
Preterm birth (PTB; <37 completed weeks of
gestation) represents one of the most significant concerns for perinatal health.1 PTB is
the leading cause of infant mortality and has
been associated with a large number of negative consequences, including higher rates

Strengths and limitations of this study
►► Pregnancy, Race, Environment, Genes encompassed

approximately 1100 person time points across the
gestational and postpartum periods, making it the
one of the largest longitudinal studies of preterm
birth to incorporate genetic, epigenetic and environmental measures.
►► The experimental design provides traction for the
testing of causal hypotheses on the contribution of
risk to preterm birth and major depression in the
peripartum.
►► Both the environmental exposure and biological
data are multidimensional: environmental exposure
data incorporates both objective and self-report exposure measures, and the biological data include
genome-wide DNA methylation (DNAm) measurements, gene expression profiles, telomere length
and micronuclei frequency.
►► Due to the resources allocated to increase the depth
of phenotyping, the number of individual women
followed is modest; however, even large cross-sectional studies are not amenable to testing causal
mechanisms.
►► DNAm measurement with the Illumina Infinium
HumanMethylation 450 BeadChip interrogates a
relatively small fraction of all CpG sites in the genome; however, the probes target regions of known
functional importance, and the 450 k is one of the
most frequently used platforms, which will facilitate
standardised comparisons with other studies.

of cerebral palsy, respiratory illness, feeding
difficulties, neurological disabilities, vision
problems and learning difficulties.1 PTB also
represents a persistent health disparity with
African-American (AA) women in the USA
being at a significantly higher risk to experience PTB. A large number of social and environmental determinants of health (SEDH)
have been suspected as risk factors for PTB,
but socioeconomic models have failed to
account for the differences in PTB rates. One
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possible reason that efforts to account for racial differences in PTB rates using non-genetic measures have
been unsuccessful2 could be that research on SEDH and
biological processes has been disconnected in the PTB
literature. Genetic studies should be directed to understand racial differences in the sociocultural sources
of environmental heterogeneity that exist within and
between races.3
Substantial evidence from twin and family studies
points to both genetic and environmental factors contributing to the risk liability of PTB, but the contribution
of each depends on maternal self-reported race.3 This
difference is not surprising given that heritability estimates assess the relative importance of genes and environments, are population-specific and are not necessarily
constant across populations, especially if there are known
disparities in environmental exposures. For example,
although height is a highly heritable trait, observed
differences in mean height between populations are
largely attributable to environmental differences such as
diet and quality of health care.4 Population differences
in terms of genetic and environmental contributions can
reveal factors responsible for racial differences in health
outcomes. Recently, biometrical models that simultaneously account for both genetic and environmental factors
have shown environmental sources contributed 3.1 times
more to the risk liability of PTB in AA compared with
European-Americans (EA).3
In conjunction with these results, multiple lines of
evidence support the primacy of social inequities for
racial health disparities, including PTB rates.5 The PTB
rate in 2003 for the US-born AA was 18.2% but 13.9%
for foreign-born AA, which is a rate similar to that of
EA.6 Because the US-born and foreign-born AA women
are expected to share similar genetic ancestry, these
results support, in part, a sociodemographic explanation for the disparate PTB rates between foreign-born
and the US-born births. Broad categories of non-genetic
factors thought to contribute to racial disparities include
social factors, such as maternal education; marital status;
stressful life events, such as maternal exposure to financial, partner-associated or traumatic stress; racism and
environmental factors including pollution, water quality,
tobacco exposure and diet.7–9
Despite insight into risk factors that could be contributing to PTB liability, past research has failed to elucidate
causal mechanisms integral to PTB pathophysiology, in
part due to incomplete phenotyping and a lack of longitudinal sample collection.10 Many of the risk factors are
inherently entangled and occur at different frequencies
over the life course. Moreover, the timing and frequency
of risk factors can affect how much they impact health
outcomes.11 Differences in risk factor prevalence are
expected to drive the environmental heterogeneity that
contributes to racial health disparities, but attributing
causality to environmental variables is difficult for a
number of reasons, not least because many risk factors
are correlated with self-identified race. For these reasons,
2

precise, repeated environmental measurements across
the entire gestational period are critical to providing
insight into causal factors that contribute to perinatal
outcomes.
The Pregnancy, Race, Environment, Genes (PREG)
study was designed to address the complexity of estimating the factors that contribute to racial health disparities in perinatal outcomes in several ways. First, the
PREG study used repeated sampling of biological and
environmental measures over the course of pregnancy to
test aetiological models of causal relationships between
environmental and biological measures. The study design
was guided by the presence of environmental heterogeneity between races, environmentally influenced changes
in gene expression (GE), contribution of both fetal and
maternal genetic factors to gestational age at birth and
the appreciation that individual differences in complex
traits are best understood through gene-environment
interactions. Second, both environmental and biological measures obtained from multiple sources were
collected over the course of pregnancy (eg, self-report,
objective measures, medical records, blood from infant
and mother), which allows thorough phenotyping of
environmental and biological factors, and leverage to
investigate their relationships over time. Third, the PREG
study included two postpartum assessments to test similar
mechanistic hypotheses regarding major depression in
the peripartum (MDP), defined as an episode of major
depressive disorder that onsets either during pregnancy
or within 4 weeks postpartum.12
Conceptual model overview
Current literature supports a ‘complex, multifactorial
causal framework’ describing racial disparity in birth
outcomes.13 Figure 1 illustrates a theory-driven, developmental model of potential environmental and biological
contributions to PTB. Arrows from each aetiologic factor
correspond to established or theoretically possible causal
pathways. This model is based on empirical evidence
demonstrating: (1) epidemiological support for SEDH
contributing to poor pregnancy outcomes14; (2) the
effect of pregnancy-specific environments (PSE) on birth
outcomes15; (3) changes in DNAm following either differential GE or environmental exposures in both human16
and animal models17; (4) changes in GE following DNAm
changes and/or environmental exposures18; (5) association of DNAm and GE profiles with PTB19 20 and birth
outcomes; (6) influence of sequence variation on methylation (mQTL) and GE (eQTL) levels21 and (7) the consistent and pervasive association of race with environmental
risk factors and poor pregnancy outcomes.22 The model
allows for tests of mediation by DNAm and GE on the
association between environmental exposures and PTB
and the moderating effects of DNA sequence on DNAm
and GE.
The overall hypothesis to be tested is that social and
stressful environments exert their biological effects on
physiological and pathological functioning by regulation
Lapato DM, et al. BMJ Open 2018;8:e019721. doi:10.1136/bmjopen-2017-019721
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Figure 1 This model illustrates the relationships between environmental factors (left) and how each may affect biological
processes (bottom) important to the timing of birth either directly (eg, PSE→DNAm) or indirectly (PSE→DNAm→GE). Chronic
stressors are represented by SEDH. Many of those factors are correlated with race and will influence the type of environment
a woman experiences during pregnancy. Single headed arrows represent possible causal pathways based on empirical
evidence that links SEDH to poor birth outcomes. This framework allows for tests of mediation via DNAm and GE and of
moderation effects of DNA sequence (eQTLs/mQTLs). DNAm, DNA methylation; GE, gene expression; PSE, pregnancy-specific
environment; PTB, preterm birth; SEDH, social and environmental determinants of health; SNP, single nucleotide polymorphism
moderating DNA methylation (mQTL) or GE (eQTL).

of GE in key biological response networks. Environmental
risk relevant to pregnancy outcomes can be partitioned
into two general groups: (1) those that are established
before pregnancy and result in sources of chronic stress
(SEDH) and (2) environmental factors that are initiated
and can change during pregnancy (PSE). SEDH factors
are expected to contribute and correlate with PSE factors.
For instance, chronic stress manifested by living in an
unsafe neighbourhood before pregnancy is a SEDH, while
witnessing a neighbourhood crime during pregnancy
would be a PSE factor. In the current model, the SEDH
construct of chronic stress is consistent with the ‘weathering’ hypothesis in which cumulative impact of lifelong
social and environmental adversity correlates with deteriorating reproductive health.14 There can be a ‘direct’
effect of SEDH on PTB as indicated by the causal arrow
in figure 1 (SEDH→PTB), an ‘indirect’ effect through
mediating pathways (SEDH→DNAm→GE→PTB) or
both. Indirectly, SEDH could influence PTB risk through
the PSE. For instance, socioeconomic status or maternal
education are best viewed as SEDH constructs that
could directly influence a pregnant mothers’ access to
prenatal care or a healthy diet. Mechanistic insight into
Lapato DM, et al. BMJ Open 2018;8:e019721. doi:10.1136/bmjopen-2017-019721

how different SEDH constructs influence PTB can be
elucidated through indirect paths to PTB. Lack of social
support, ineffective coping strategies and high levels of
perceived stress could be associated with epigenetic and
GE pathways involved in neuroendocrine deregulation
while poor health-related behaviours and neighbourhood environments23 might elicit gene networks regulating host-pathogen immune response. Longitudinal
assessments of PSE and DNAm allow for the assessment
of change in these measures and causal relationships
between constructs during pregnancy. The conceptual
model as presented is specific to racial disparities in gestational age outcomes, but is equally applicable to investigations into other perinatal outcomes like MDP.
Cohort description
Participant eligibility and recruitment
Eligible women were aged 18–40 years with singleton
pregnancies and no diagnosis of diabetes or indication of
assisted reproductive technology. Women over the age of
40 years were excluded because they were more likely to
have age-related pregnancy complications or be referred
3
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to a high-risk clinic.24 In addition, both mother and father
had to self-identify as either both EA or both AA and be
absent of Hispanic or Middle Eastern ancestry. Exclusion
criteria at birth included any congenital abnormality, polyhydramnios/oligohydramnios, pre-eclampsia/pregnancy-induced hypertension (PIH)/haemolysis, elevated liver
enzymes, low platelet count (HELLP), Rh sensitisation,
abruptio placentae, placenta previa, cervical cerclage,
medically necessitated preterm delivery and drug abuse.
Women participating in fewer than three study time point
assessments (including birth) were excluded. Starting in
2014, women meeting the above criteria were eligible
to continue into the postpartum extension (cord blood
collection was not required).
PREG recruitment began in 2013 and ended by Spring
of 2016. The PREG study employed a research nurse to
manage and implement recruitment activities at VCU
Medical Center Nelson Clinic in downtown Richmond,
Virginia and at VCU Medical Center at Stony Point Clinic.
The research nurse reviewed appointment records to
identify women attending for routine well-baby prenatal
visits. Potential research participants were approached in
the clinic waiting rooms and, if interested, were provided
with a brief summary of the research project opportunity and a participant volunteer brochure. In addition,
brochures and flyers describing the study were placed
in and around the clinics. All study flyers and brochures

included contact information for women interested in
participating in PREG.
Study design
Women who were in early pregnancy (<24 weeks gestation)
were eligible to enrol in the PREG study if they met all
inclusion criteria. Peripheral blood and a detailed inventory of SEDH were assessed via questionnaires to establish
baseline. Follow-up questionnaires designed to measure
PSE factors were obtained at three follow-up visits along
with maternal peripheral blood. Umbilical cord blood
was collected at birth (table 1; see online supplementary
figure S1 for study flow diagram). Additional information
for mother and child was obtained by the study research
nurse through medical records abstraction. The goal
was to conclude the study with n=200 women meeting
all inclusion and no exclusion criteria. Thus, an additional 40 participants (20%) were consented to account
for attrition and late pregnancy-related study exclusions.
While the final target sample size is modest compared
with other epidemiological investigations, the depth of
the phenotyping and the longitudinal, repeated nature
of the data provides traction for characterising the pathways that mediate effects of the environment on PTB that
might be too small to be detected individually.
Items of small monetary value were provided as
gifts to participants at each study visit (eg, ultrasound

Table 1 Sample collection schedule for PREG and the MDP extension
PREG time points (weeks gestation)

MDP time points

Measure

0–15

10–25

20–40

37–42

Birth

6 weeks

6–12 months

Maternal data*
 SEDH survey

232

–

–

–

–

–

–

 PSE survey

232

185

192

147

–

105

57†

 DNAm

234

190

183

161

–

107

55†

 Gene expression

–

–

–

159

–

–

–

 GWAS‡

234

–

–

–

–

–

–

 Telomere length

234

–

–

–

–

–

–

 Micronuclei

234

–

–

–

–

–

–

 NIfETy§

139

–

–

–

–

–

–

 DNAm

–

–

–

–

136

–

–

 Gene expression
 Telomere length

–
–

–
–

–
–

–
–

87
136

–
–

–
–

Child data (newborn)¶

The numbers shown in the table represent the number of samples collected. Only samples from participants who met all birth inclusion
criteria will be processed.
*DNAm, gene expression, GWAS, telomere length and micronuclei measurements using peripheral blood.
†Approximately half of the participants who continued to the MDP extension aged out before the second postpartum visit because funding
was not obtained until 2014.
‡Intended to identify methylation quantitative trait loci.
§NIfETy ratings were completed either during pregnancy or within 1 year of birth.
¶DNAm, gene expression and telomere length measured in umbilical cord blood.
DNAm, DNA methylation; GWAS, genome-wide association study; MDP, major depression in the peripartum; NIfETy, Neighbourhood Inventory
for Environmental Typology; PSE, pregnancy-specific environment; SEDH, social and environmental determinants of health.
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picture magnet frames, onesies, swaddling blankets).
Women also were compensated financially at each
visit for their study participation. In 2014, additional
funding was obtained to follow PREG participants for
up to 1 year postpartum. The sample size goal for the
postpartum extension was n=100 because by the time
the additional funding was received, around half of the
PREG sample had been recruited already. Research
participants completing all required PREG study visits
were contacted and offered the opportunity to participate in the MDP extension and enrolled if they met
all PREG birth inclusion criteria. The MDP study extension included two additional visits, during which additional blood draws and questionnaires were collected
along with medical records abstraction. The first blood
draw occurred 6–8 weeks postdelivery and the second
within a year postdelivery.
IRB approval, privacy and informed consent
The research nurse conducted the informed consent with
all research participants at recruitment. The study design,
rationale and aims were described to participants, and
ample time was provided to answer questions. Informed
consent was obtained separately for eight different
aspects of the study, including medical data abstraction,
cord blood collection and long-term sample storage for
future reproductive research studies. Participants could
opt out of any part of the study. In 2014–2016, additional
grant funding was obtained to collect two additional MDP
study visits after delivery to assess onset and indicators of
perinatal depression.
Data collection and handling procedure
Questionnaires
Self-report questionnaires were collected at four pregnancy visits (table 1) to measure SEDH and PSE exposures (see online supplementary table S1). Surveys
were completed using the Research Electronic Data
Capture (REDCap) software on tablet computers.
REDCap is a web-based application that can create,
distribute and store data securely from questionnaires.
The research nurse and trained student assistants
were present to help participants with any questions
regarding the software or to clarify questionnaire items.
If anyone needed more time or preferred to complete
the questionnaire at home, they were emailed a link.
Blood samples
Maternal peripheral blood was drawn during each of the
four pregnancy visits by the research nurse. Every attempt
was made by the research nurse to coordinate study blood
draws with clinic blood draws as part of usual care to minimise extra needle sticks. Cord blood was collected immediately following birth by either the research nurse or
trained members of the Labor and Delivery Department,
depending on availability. In the event that a cord blood
sample was missed at birth, the research nurse retrieved
umbilical cord specimens that were refrigerated for later
Lapato DM, et al. BMJ Open 2018;8:e019721. doi:10.1136/bmjopen-2017-019721

testing. These samples were suitable for DNAm analysis
but not GE.
Medical records abstraction
Pregnancy and birth outcome data from patient records
was accessed by the research nurse using the CERNER
medical records service and entered into a REDCap form.
After each visit, the research nurse reviewed prenatal visit
notes and verified inclusion criteria were still being met.
Neighbourhood Inventory for Environmental Typology
Neighbourhood Inventory for Environmental Typology
(NIfETy) assessments were performed for PREG participants who lived within a 1 hour drive from Richmond,
Virginia, and were located in either an urban or suburban
area.25 Participants who lived in rural areas were excluded
because the NIfETy tool was designed to rate neighbourhood blocks. All neighbourhood evaluations were
performed by pairs of trained raters during the daytime,
and raters knew which block to rate but not which house
belonged to a participant.
Depth and breadth of environmental and biological data
Environmental assessment
Questionnaires
The initial questionnaire included 1328 questions, took
approximately 40–90 min to complete and covered a wide
range of topics spanning lifetime exposures to trauma,
neighbourhood quality, perceived stress, pregnancy-specific stress, lifestyle, housing and food security and lifetime and current symptoms of depression, anxiety and
substance use (see online supplementary table S1).
Follow-up pregnancy questionnaires at visits 2–4 were
a subset of the baseline and specifically inquired about
stressors and experiences that happened since the last
PREG questionnaire. They required approximately
30–60 min to complete. For the postpartum visits, questionnaires included 83 questions and took about 30 min
to complete. The response rate for key variables in baseline questionnaires is shown in table 2 for PREG participants who met all inclusion criteria and no exclusion
criteria. Questionnaire data from the MDP study extension is currently being finalised.
Neighbourhood Inventory for Environmental Typology
The NIfETy instrument provides a detailed assessment
of neighbourhood social and environmental factors,
including access to public transportation and recreational outlets, indicators of violence and drug use and
physical layout (eg, presence of sidewalks, amount of car
and foot traffic, etc). In total, the assessment collects >130
variables and provides an objective measure of environmental exposures.
Biological/biomarker measurements
The major focus for the biological data collection was
genome-wide DNA methylation (DNAm) measurement
from maternal peripheral blood and infant cord blood.
DNAm is an epigenetic modification responsible in
5
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Table 2 Demographic characteristics of PREG study participants
AA

EA

Response rate (AA | EA) Significance

50.3% (89)
272.5 (10.5)

49.7% (88)
277.6 (8.3)

 –
100% | 100%

–
<0.0001

Age*

27.0 (5.5)

31.0 (3.4)

100% | 100%

<0.0001

Body mass index*

29.1 (8.9)

25.4 (5.2)

99% | 100%

<0.0001

Participants (%, N)
Gestational age at birth*†

Current smoker

11.2% (10)

1.1% (1)

94% | 97%

<0.0001

No health insurance before pregnancy

20.2% (18)

2.3% (2)

100% | 100%

<0.0001

First pregnancy

21.3% (19)

43.2% (38)

97% | 97%

0.002

No prenatal vitamin‡

65.2% (58)

10.2% (9)

97% | 97%

<0.0001

100% | 97%

<0.0001

99% | 98%

<0.0001

100% | 98%

<0.0001

99% | 98%

<0.0001

Relationship status
 Married/in a relationship

66.3% (59)

94.3% (83)

 Single

29.2% (26)

0.0% (0)

 Other§

1.8% (2)

4.0% (5)

 Did not answer

5.3% (6)

4.8% (6)

Employment¶
 Full

21.3% (19)

67.0% (59)

 Part

28.1% (25)

18.2% (16)

 Student

21.3% (19)

5.7% (5)

 Unemployed

37.1% (33)

8.0% (7)

Educational attainment
 Did not complete HS

22.5% (20)

1.1% (1)

 Completed HS/GED

34.8% (31)

3.4% (3)

 Some college

28.1% (25)

12.5% (11)

 Completed college/professional
degree

12.4% (11)

80.7% (71)

 <US$60 000

73.0% (65)

56.8% (50)

 >US$60 000
 Do not know/prefer not to answer

2.2% (2)
23.6% (21)

39.8% (35)
1.1% (1)

Household income

Categorical tests were performed using two-sided Fisher’s exact tests and Student’s t-tests were applied to quantitative variables.
*Mean (SD).
†Measured in days.
‡Assessed in SEDH questionnaire given at first visit.
§Separated or never married.
¶Only unemployment status was tested for significance because many full-time and part-time employees were also students.
AA, African-American; EA, European-American; GED, General Equivalency Diploma; HS, Highschool; PREG, Pregnancy, Race, Environment,
Genes; SEDH, social and environmental determinants of health.

part for maintaining chromatin structure and modulating gene regulation.26 Changes in DNAm can result
in altered GE, and aberrant DNAm profiles have been
associated with constitutional and acquired abnormalities like imprinting disorders27 and cancer,28 respectively.
Together, the DNAm data from the dyad and maternal
SEDH and PSE measurements can provide insight into
the degree of similarity between maternal and infant
DNAm profiles and how maternal environmental exposures affect infant DNAm and epigenetic age.29–31
Genome-wide DNAm measurements were performed
on maternal blood at four time points during pregnancy
and on cord blood samples using Illumina Infinium
6

HumanMethylation 450 BeadChip (450 k).32 Maternal
postnatal DNAm assessments were performed using the
EPIC 850 BeadChip (850 k),33 which includes >90% of the
450 k probe set. Both microarrays provide standardised
measurements of DNAm in intragenic and intergenic
regions, covering >99% of RefSeq genes. The DNAm
measurements overlapping or near single nucleotide
polymorphisms can be leveraged to generate ancestry-relevant principal components, which can be incorporated
as covariates in multivariate models.34 Analytic pipelines
developed for 450 k data are relevant for analysing data
from the 850 k,35 and methods exist for combining datasets with a mixture 450 k and 850 k data.36
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In addition to DNAm, GE, telomere length and micronuclei prevalence were measured. GE was assayed in
maternal peripheral blood and infant cord blood using
the GeneChip Human Genome U133 Plus 2.0 Array
(U133 Plus). The U133 Plus microarray assays >47 000
transcripts and variants and includes all of the probe sets
from the U133A 2.0, U133A and U133B microarrays.37 38
These data can be used to determine which DNAm marks
are directly associated with GE. Both telomere length and
micronuclei prevalence are thought to be biomarkers
of cellular ageing and health.39 Telomeres are repetitive DNA sequences found at the ends of every chromosome. Their lengths have been associated with overall
genomic stability,40 can be a useful marker of long-term
stressors, and were measured via quantitative PCR. Micronuclei are small chromatin-containing structures that
neighbour parent cells and arise from the exclusion of a
whole or partial laggard chromosome following mitotic
cell division. This cytological phenomenon is used as
an end point to quantify chromosomal instability.41
The presence of micronuclei has been associated with
recent and lifetime exposures to cytotoxic and genotoxic
agents.42 43 Both average telomere length and micronuclei prevalence were assessed only at baseline to estimate
the impact of prepregnancy environmental exposures to
genomic and cellular health. GE was measured on the visit
before pregnancy to assess which DNAm marks measured
during previous study visits may have influenced gene
transcription levels in maternal peripheral blood later in
pregnancy.

Findings to date
Response and retention rates
Of the 240 women enrolled in the PREG study, 177 women
(AA=89, EA=88) met full inclusion criteria, and 126
(71.2%) participants completed at least three pregnancy
visits in addition to cord blood collection. The PREG study
maintained a favourable retention rate (74%), and of the
63 participants who met exclusion criteria, 44 (69.8%)
were for a medical reason. The most common cause of
exclusion was miscarriage (n=17), followed by presence
of pre-eclampsia/PIH/ HELLP (n=12). Adequate cord
blood samples were collected from n=136 participants
(AA=66; EA=70). To date, 139 NIfETy ratings have been
completed. Enrolment for the MDP extension concluded
with 104 participants consented (AA=50; EA=54).
Demographic structure
Demographic information was collected through self-report questionnaires and medical records abstraction
(table 2). Mean age for AA participants was significantly
less than for EA participants (27.0 years (SD=5.5) vs 31.0
years (SD=3.4)) and mean BMI was significantly greater
in AA participants (29.1 (SD=8.9) vs 25.4 (SD=5.2)).
Almost half (42%) of the EA women and 22% of AA
women were primiparous. Other significant group differences included use of prenatal vitamins (35% AA used
Lapato DM, et al. BMJ Open 2018;8:e019721. doi:10.1136/bmjopen-2017-019721

vs 90% EA), relationship status (29% AA single vs 0%
EA) and presence of health insurance prior to pregnancy
(20% AA did not have health insurance before pregnancy
vs 2% EA).
Mean gestational length at birth was significantly
less for the AA participants by 5.1 days in PREG study
participants (272.5 (SD=10.5) days vs 277.6 (SD=8.3)).
Women who continued to the postpartum extension
did not differ significantly by race, maternal age, gestational age at birth, income, education, prenatal vitamin
use or relationship, unemployment or student status
from PREG participants who did not met any pregnancy
or birth exclusion criteria. Multiple regression analysis
was used to estimate the amount of explained variance
of frequently used covariates assessed in socioeconomic
models (eg, years of education, relationship status, primiparity, maternal age, maternal BMI and smoking history)
on gestational age at birth. These predictors, assessed at
baseline, accounted for 9.7% of the variance in gestational
age at birth (adjusted R2=6.3%). This set of variables both
explains a modest amount of variance in gestational age
at birth and is associated with self-identified race, which
makes each variable in the set ideal to test as candidates
for mediating the influence of race on gestational age at
birth. Further tests can uncover DNAm loci that participate in the identified mediating pathways.
Strengths and limitations
Strengths
Phenotyping quality
A key strength of the PREG study is the scope and quality
of repeated PSE measures collected over the course of
the peripartum period, which is not typically seen in
other studies. This study design allows for modelling
relationships between environmental (SEDH and PSE)
and biological (eg, DNAm, telomere length) variables,
assessing how SEDH and PSE influence DNAm, and
testing causal hypotheses for multiple perinatal outcomes
of interest, including PTB and MDP. The dataset incorporates objective and self-reported environmental measures
and multiple biological measures, including DNAm and
GE measures. Very few datasets currently exist outside of
cancer research that include genome-wide DNAm and
GE measures, and PREG includes paired DNAm and
GE measures for both mother and infant. Additionally,
daily measurements of environmental contaminants and
pollutants, such as carbon monoxide, lead, sulfur dioxide,
particulate matter and ozone, have been obtained from
the Virginia Department of Environmental Quality archive
for 2013–2016.44 These data come from 11 monitoring
stations around Virginia, including one in Richmond,
and provide insight into annual and seasonal differences
in regional levels of pollution. Other longitudinal studies,
such as the Global Alliance to Prevent Prematurity and
Stillbirth (GAPPS),45 also have collected data from self-report questionnaires and multiple tissue sources; however,
a major difference between PREG and GAPPS is that the
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GAPPS questionnaires focus on medical history, medication use, gynaecological and sexual history and lifestyle
choices (eg, diet) rather than constructs important to
stress and weathering. Items to measure coping and stress
are present, but they are not the emphasis. PREG questionnaires thoroughly interrogated personal history of
trauma, coping efforts, self-esteem, social support and job
stress occurring before and during pregnancy to capture
comprehensive and robust assessments of SEDH and PSE.
The PREG study has the potential to increase understanding of how SEDH and PSE exposures influence risk
for adverse perinatal outcomes and affect racial health
disparities in perinatal outcomes. Furthermore, the
repeated measures of DNAm will provide insight into
how DNAm changes over the course of pregnancy and
how SEDH and PSE influence DNAm temporal patterns.
The PREG study results have the advantage of potentially
being generalisable to a large proportion of the US population since the sample includes AA and EA participants
and the rates of PTB and depressive symptoms are representative of much of the US population.
Recruitment, retention and response rates
Research studies targeting pregnant women and
under-represented populations present unique challenges for recruitment compared with those from the
general population. We found that using a sole research
nurse to coordinate scheduling and research visits was
able to meet ascertainment goals and minimised participant attrition rates. The vast majority of participants
who dropped out of the study were excluded for medical
reasons. Of the 19 participants who left for non-medical
reasons, only 4 participants requested to leave the PREG
study. Eight moved out of the area and/or changed
providers. Participants did not seem discouraged from
enrolling in this study, which included multiple study
visits and lengthy questionnaires. One reason for this positive reception was that every effort was made to schedule
study visits during prenatal care visits to maximise convenience for participants, including the ability to start the
questionnaire in the clinic and the option of finishing at
home since the data capture tool use was web-based.
Transparent data processing
All self-report data were collected through REDCap and
processed using automated R scripts. Using electronic
data collection and automated processing reduces the
likelihood of human error during data transfer and
provides a highly efficient, transparent and reproducible way to process and analyse data. Moreover, many
electronic methods have features that ease collaboration
efforts. For example, REDCap can generate data dictionaries that concisely display variable names, which facilitates data requests and sharing.
Limitations
The investment in collecting repeated measurements
restricted the total number of pregnant women that could
8

be recruited. While the size of the cohort is modest, it
includes approximately 1100 person time points of data.
Moreover, longitudinal data from a medium-sized cohort
provides insights unavailable even to large cross-sectional studies and provides a framework for testing causal
hypotheses. In addition, the presence of at least four time
points of data allows for the assessment of non-linear
growth models.
Having a single research nurse meant that at every
visit, participants saw a familiar face, and in between
visits, they had a single point of contact; however, being
the sole liaison required extensive planning, especially
on days when the research nurse needed to travel to
multiple clinics to collect either peripheral blood or
umbilical cord blood. Moreover, sometimes it was not
possible for the research nurse to be present to collect
cord blood samples, which required coordinating with
hospital labour and delivery personnel to ensure collection occurred.
Lessons
Maintaining high retention rates
One of the most influential factors that contributed to
the retention rate was the research nurse. This person
was the primary contact for all PREG study participants
regardless of recruitment site. Providing multiple communication options for contacting the research nurse (eg,
email, phone, text) combined with establishing a reliable and familiar contact fostered a strong rapport with
participants.
Coordinating with clinical recruitment sites
As skilled clinicians, research nurses are ideal team
members for studies that either recruit or collect samples
in medical environments (eg, hospitals, clinics, etc).
Their nursing training allows them to integrate quickly
and adapt into varying clinical environments, which facilitates good rapport with clinical staff. Medical doctors and
nurses at recruitment sites coordinated with the PREG
research nurse so that questionnaires could be distributed and blood draws obtained during normal prenatal
care visits without disrupting care.
Including research nurses as part of the study team can
also improve participant experience. The clinical training
nurses receive can help to identify and handle potentially
sensitive situations with care. This skill is especially beneficial for studies recruiting in environments that people
could be visiting for very different reasons. For example,
whenever possible, the PREG research nurse screened
medical charts before approaching potential participants
to verify that they were not in clinic for fetal loss or other
pregnancy complications.

Future plans and collaboration
Additional biomarker processing is ongoing and includes
DNA sequencing, GE analysis, global telomere length
measurement and assaying micronuclei frequencies.
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Initial NIfETy neighbourhood assessments have been
completed, and the secondary ratings to assess reliability
will be completed by early 2018. Researchers interested
in using PREG data are encouraged to contact the corresponding author for more information regarding data
availability.

Conclusion
The longitudinal design of the PREG study provides
traction to investigate causal relationships between environmental exposures and both DNAm and perinatal
outcomes. The scope and quality of data will support
investigations in many closely related research areas
pertaining to pregnant women, including stress, trauma,
racial health disparities and coping efforts.
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